Complete remission duration and long-term survivors (LTS) in chronic myelogenous leukaemia (CML): a theoretical approach to a clinical decision.
Fondevila
C G
CG
Santarelli
M T
MT
Fernandez
J
J
D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality*; D012074:Remission Induction; D013997:Time Factors